Corthotec

Corthotec is a UK start-up developing an innovative treatment to catalyse bone fracture healing - helping broken bones heal faster.

  • Stage Product In Development
  • Industry Biotechnology
  • Location London, UK
  • Currency GBP
  • Founded March 2016
  • Employees 5
  • Incorporation Type LLC
  • Website corthotec.com

Company Summary

• Recent meetings with regulators, including MHRA, suggest Corthotec will be able to pursue a preclinical development pathway in 2019, positioning it for clinical trials in 2020.
• Patent filed with UK IPO (P/61974). To be back dated to submission date - and applied across EU. Parallel filing with USPTO.
• UK Innovate grant of £150,000.
• Initial EU grant of £41,000.
• SEIS/EIS approved.

Previous Investors

  • Robert Ferran
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free